Company intelligence / Profile preview

Ampersand Capital Partners

Boston / Wellesley / Bedford*, Massachusetts, United Statesampersandcapital.com ↗

Ownership: Private
Development stage: Other

Overview

Ampersand Capital Partners invests in growth-stage healthcare and life sciences companies across the value chain—including pharma services/CROs/CDMOs/CMOs/lab services/diagnostics/devices—helping build market leaders by providing capital and strategic guidance. They do not conduct clinical trials or develop drugs directly.

Industry: Investors

Partnerships

Partnerships are typically with founders/executive teams of their portfolio companies.No major pharmaceutical or biotech partnerships as an operating entity.

Beyond the preview

Go deeper on Ampersand Capital Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ampersand Capital Partners.

Explore the full profile